SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$16,000
+14.3%
2,5000.0%0.01%0.0%
Q4 2013$14,000
-6.7%
2,5000.0%0.01%
-16.7%
Q3 2013$15,0000.0%2,5000.0%0.01%
+20.0%
Q2 2013$15,0002,5000.01%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 525,000$2,956,0001.06%
First Light Asset Management, LLC 170,804$962,0000.82%
PFM Health Sciences, LP 5,047,119$28,415,0000.57%
Rhenman & Partners Asset Management AB 250,000$1,408,0000.55%
NEA Management Company, LLC 1,935,300$10,896,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 544,779$3,067,0000.43%
APEX CAPITAL, LLC 1,000,000$5,630,0000.37%
Partner Investment Management, L.P. 240,221$1,352,0000.31%
Hudson Bay Capital Management LP 1,002,405$5,644,0000.23%
BAILARD, INC. 243,300$1,370,0000.22%
View complete list of OREXIGEN THERAPEUTICS INC shareholders